A Unique Mdm2-Binding Mode of the 3-Pyrrolin-2-one- and 2-Furanone-Based Antagonists of the p53-Mdm2 Interaction.
Surmiak, E., Twarda-Clapa, A., Zak, K.M., Musielak, B., Tomala, M.D., Kubica, K., Grudnik, P., Madej, M., Jablonski, M., Potempa, J., Kalinowska-Tluscik, J., Domling, A., Dubin, G., Holak, T.A.(2016) ACS Chem Biol 11: 3310-3318
- PubMed: 27709883 
- DOI: 10.1021/acschembio.6b00596
- Primary Citation of Related Structures:  
4ZFI, 4ZGK - PubMed Abstract: 
The p53 pathway is inactivated in almost all types of cancer by mutations in the p53 encoding gene or overexpression of the p53 negative regulators, Mdm2 and/or Mdmx. Restoration of the p53 function by inhibition of the p53-Mdm2/Mdmx interaction opens up a prospect for a nongenotoxic anticancer therapy ...